These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 16334979)

  • 1. CC chemokines and chemokine receptors in IgA nephropathy (IgAN) and in non-IgA mesangial proliferative glomerulonephritis (MesProGN). the immunohistochemical comparative study.
    Wagrowska-Danilewicz M; Danilewicz M; Stasikowska O
    Pol J Pathol; 2005; 56(3):121-6. PubMed ID: 16334979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A correlation between immunoexpression of CD44, alpha-SMA and CD68+ cells in IgA-nephropathy and in mesangial proliferative IgA-negative glomerulonephritis.
    Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2002; 53(3):155-62. PubMed ID: 12476618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significant role of RANTES and CCR5 in progressive tubulointerstitial lesions in lupus nephropathy.
    Stasikowska O; Danilewicz M; Wagrowska-Danilewicz M
    Pol J Pathol; 2007; 58(1):35-40. PubMed ID: 17585540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: a model system to examine the role of chemokines in cell function.
    Sarau HM; Rush JA; Foley JJ; Brawner ME; Schmidt DB; White JR; Barnette MS
    J Pharmacol Exp Ther; 1997 Oct; 283(1):411-8. PubMed ID: 9336350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
    Silva TA; Garlet GP; Lara VS; Martins W; Silva JS; Cunha FQ
    Oral Microbiol Immunol; 2005 Oct; 20(5):310-6. PubMed ID: 16101967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
    Vicenzi E; Alfano M; Ghezzi S; Gatti A; Veglia F; Lazzarin A; Sozzani S; Mantovani A; Poli G
    J Leukoc Biol; 2000 Sep; 68(3):405-12. PubMed ID: 10985258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of chemokines in acute myocardial infarction.
    Kobusiak-Prokopowicz M; Orzeszko J; Mazur G; Mysiak A; Orda A; Mazurek W
    Kardiol Pol; 2005 Apr; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection.
    Lichterfeld M; Leifeld L; Nischalke HD; Rockstroh JK; Hess L; Sauerbruch T; Spengler U
    J Infect Dis; 2002 Jun; 185(12):1803-7. PubMed ID: 12085329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine receptor expression in human endometrium.
    Mulayim N; Palter SF; Kayisli UA; Senturk L; Arici A
    Biol Reprod; 2003 May; 68(5):1491-5. PubMed ID: 12606476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of the chemokine receptor, CCR5.
    Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
    Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis.
    Chen S; Liu Z; Chen H; Zhou H; Wang J; Li L
    Chin Med J (Engl); 2002 Sep; 115(9):1301-7. PubMed ID: 12411099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis.
    Segerer S; Banas B; Wörnle M; Schmid H; Cohen CD; Kretzler M; Mack M; Kiss E; Nelson PJ; Schlöndorff D; Gröne HJ
    Am J Pathol; 2004 Feb; 164(2):635-49. PubMed ID: 14742268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of chemokines and chemokine receptors with clinical features in newly diagnosed systemic lupus erythematosus].
    Tao JH; Li XP; Li XM; Kan M; Zhai ZM; Wang W
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3051-4. PubMed ID: 17288835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
    Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
    J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
    Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
    J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-chemokine function in experimental lung ischemia-reperfusion injury.
    Krishnadasan B; Farivar AS; Naidu BV; Woolley SM; Byrne K; Fraga CH; Mulligan MS
    Ann Thorac Surg; 2004 Mar; 77(3):1056-62. PubMed ID: 14992926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production.
    Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S
    Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
    Crane IJ; McKillop-Smith S; Wallace CA; Lamont GR; Forrester JV
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1547-52. PubMed ID: 11381059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases.
    Furuichi K; Wada T; Sakai N; Iwata Y; Yoshimoto K; Shimizu M; Kobayashi K; Takasawa K; Kida H; Takeda SI; Mukaida N; Matsushima K; Yokoyama H
    Am J Nephrol; 2000; 20(4):291-9. PubMed ID: 10970982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.